3-(alpha-l-arabinopyranosyl)-1-methyl-1-nitrosourea and Malignant Melanoma

3-(alpha-l-arabinopyranosyl)-1-methyl-1-nitrosourea has been researched along with Malignant Melanoma in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Afanasyeva, D; Baryshnikova, M; Belyаvsky, A; Burova, O; Misyurin, V; Shprakh, Z; Vartanian, A	1
Akimov, MA; Gershanovich, ML	1
Borodkina, AG; Egorov, GN; Gorbunova, VA; Manziuk, LV; Orel, NF; Semina, OV	1

Trials

1 trial(s) available for 3-(alpha-l-arabinopyranosyl)-1-methyl-1-nitrosourea and Malignant Melanoma

Article	Year
[Chemoimmunotherapy with dacarbazine and aranose combined with interferon-alpha in disseminated cutaneous melanoma]. Voprosy onkologii, 2004, Volume: 50, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Female; Glycosides; Humans; Immunologic Factors; Interferon-alpha; Male; Melanoma; Methylnitrosourea; Middle Aged; Skin Neoplasms; Treatment Outcome	2004

Other Studies

2 other study(ies) available for 3-(alpha-l-arabinopyranosyl)-1-methyl-1-nitrosourea and Malignant Melanoma

Article	Year
Inhibitor of vasculogenic mimicry restores sensitivity of resistant melanoma cells to DNA-damaging agents. Melanoma research, 2017, Volume: 27, Issue:1 Topics: Antigens, Neoplasm; Antineoplastic Agents, Alkylating; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carbazoles; CD24 Antigen; Cell Line, Tumor; Drug Resistance, Neoplasm; Endoglin; Fluorescent Dyes; Gene Expression; Glycosides; Humans; Hyaluronan Receptors; Intercellular Adhesion Molecule-1; Male; Melanoma; Methylnitrosourea; Middle Aged; Neoplasm Proteins; Neoplastic Stem Cells; Neovascularization, Pathologic; Nuclear Proteins; Phenotype; Phosphoprotein Phosphatases; Proto-Oncogene Proteins c-kit; Rhodamine 123; Tetraspanin 30	2017
[Aranoza -- a new Russian antineoplastic drug]. Voprosy onkologii, 2001, Volume: 47, Issue:6 Topics: Antineoplastic Agents; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Therapy, Combination; Glycosides; Humans; Infusions, Intra-Arterial; Interferon-alpha; Melanoma; Methylnitrosourea; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Time Factors	2001

Article

Year

Inhibitor of vasculogenic mimicry restores sensitivity of resistant melanoma cells to DNA-damaging agents.

Melanoma research, 2017, Volume: 27, Issue:1

Topics: Antigens, Neoplasm; Antineoplastic Agents, Alkylating; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carbazoles; CD24 Antigen; Cell Line, Tumor; Drug Resistance, Neoplasm; Endoglin; Fluorescent Dyes; Gene Expression; Glycosides; Humans; Hyaluronan Receptors; Intercellular Adhesion Molecule-1; Male; Melanoma; Methylnitrosourea; Middle Aged; Neoplasm Proteins; Neoplastic Stem Cells; Neovascularization, Pathologic; Nuclear Proteins; Phenotype; Phosphoprotein Phosphatases; Proto-Oncogene Proteins c-kit; Rhodamine 123; Tetraspanin 30

2017

[Aranoza -- a new Russian antineoplastic drug].

Voprosy onkologii, 2001, Volume: 47, Issue:6

Topics: Antineoplastic Agents; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Therapy, Combination; Glycosides; Humans; Infusions, Intra-Arterial; Interferon-alpha; Melanoma; Methylnitrosourea; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Time Factors

2001